Lupus en el varón e infección dermatológica: a propósito de un caso
Keywords:
lupus, male, infectionAbstract
Introduction: systemic lupus erythematosus is a chronic, potentially fatal autoimmune disease that is frequently associated with infections.
Objective: to describe the case of a male patient with a dermatologic infection and subsequent disease activity after discontinuation of treatment.
Case presentation: 50-year-old male patient, mestizo race with a history of systemic lupus erythematosus of 20 years of evolution, lupus nephritis, suspended immunosuppressive treatment about 3 months for dermatological infection that was complicated evolving to a Pyodermitis, is hospitalized and receives broad-spectrum antibiotic treatment and Intacglobin; his dermatological condition improves but begins with elements of activity: fever, genital ulcer, pleural effusion, hypocomplementemia, proteinuria it is decided to maintain antibiotic coverage and treatment with Methylprednisolone 0. 5 gr/ 5 days and later Prednisone 60 mg/6 weeks and treatment with Mycophenolate Mofetil 2gr/day was resumed.
Conclusions: it is essential to know the infections that occur most frequently in patients with lupus, in order to achieve their prevention, diagnosis and treatment, which would have a significant impact on their survival.
Downloads
References
1-Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum [Internet]. 2012 [citado 16 Mar 2025];64(8):2677-86. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22553077/
2-Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progession of systemic lupus erythematosus. Semin Arthritis [Internet]. 2010 [citado 16 Mar 2025];39(4):257-68. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27821390/
3-Zonana-Nacach A, Camargo-Coronel A, Yañez P, Sánchez L, Jiménez-Balderas FJ, Fraga A. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus [Internet]. 2001 [citado 16 Mar 2025];10(7):505-10. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11480850/
4-Gladman DD, Hussain F, Ibañez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus [Internet]. 2002 [citado 16 Mar 2025];11(4):234-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12043887/
5-Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infections. A controlled prospective study including an epidemiological group. Q J Med [Internet]. 1985 [citado 16 Mar 2025];55(218):271-87. Disponible en: https://pubmed.ncbi.nlm.nih.gov/4023171/
6-Kim J-W, Kim H-A, Suh C-H, Jung J-Y. Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus. Front Med (Lausanne). 2022;9:906475. http://dx.doi.org/10.3389/fmed.2022.906475
7-Alarcón-Segovia D, Alarcón-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoinmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum [Internet]. 2005 [citado 16 Mar 2025];52(4):1138-47. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15818688/
8-Kanda N, Tsuchida T, Watanabe T, Tamaki K. Clinical features of systemic lupus erythematosus in men. Characteristics of the cutaneous manifestations. Dermatology [Internet]. 1996 [citado 16 Mar 2025];193(1):6-10. Disponible en: https://pubmed.ncbi.nlm.nih.gov/8864610/
9-Font J, Cervera R, Navarro M, Pallarés L, López-Soto A, et al. Systemic lupus erythematosus in men: clinical and immunological characteristics. Ann Rheum Dis [Internet]. 1992 [citado 16 Mar 2025];51(9):1050-2. Disponible en: https://pubmed.ncbi.nlm.nih.gov/1417135/
10-Varaganti V, Vadakedath S, Ca J, Kandi V, B PV, Hussain MH, et al. Mechanisms underlying gender influence on the clinical course and immunopathogenesis of systemic lupus erythematosus: An explorative review. Cureus [Internet]. 2024 [citado 16 Mar 2025];16(11):e73646. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39677179/
11-Mok CC, Lau CS, Chan TM, Wng RW. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus [Internet]. 1999 [citado 16 Mar 2025];8(3):188-96. Disponible en: https://pubmed.ncbi.nlm.nih.gov/10342711/
12-Pande N, Malaviya N, Sekharan S. SLE in Indian men: analysis of the clinical and laboratory features with a review of the literature. Lupus [Internet]. 1994 [citado 16 Mar 2025];3(3):181-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/7951303/
13-Jones JM, Smith F, Littlejohn E, Jorgensen TN. Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus Erythematosus. Front Immunol [Internet]. 2022 [citado 16 Mar 2025];13:888501. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35833144/
14-Costallat L, Coimbra A. Systemic lupus erythematosus in 18 Brazilian males: clinical and laboratory analysis. Clin Rheumatol [Internet]. 1993 [citado 16 Mar 2025];12(4):522-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/8124916/
15-Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol [Internet]. 2021 [citado 16 Mar 2025];17(9):515-32. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34345022/
16-Han JY, Cho SK, Sung YK. Epidemiology of systemic lupus erythematosus in Korea. J Rheum Dis [Internet]. 2023 [citado 16 Mar 2025];30(4):211-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37736591/
17-Bouza E, Moya JG, Muñoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am [Internet]. 2001 [citado 16 Mar 2025];15(2):335-61,vii. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11447699/
18-Kavrul Kayaalp G, Esencan D, Guliyeva V, Arık SD, Türkmen Ş, Şahin S, et al. Childhood-onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations. Lupus [Internet]. 2024 [citado 16 Mar 2025];33(10):1130-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39037381/
19-Massardo Vega L, Martínez Re ME, Baro AM, Figueroa EF, Rivero Díaz S, Jacobelli S. Infecciones en lupus eritematoso generalizado. Rev Méd Chile. 1991;119:1115-22.
20-Yuhara T, Takemura H, Akama T, Suzuki H, Yamane K, Kashiwagi H. Predicting infection in hospitalized patients with systemic lupus erythematosus. Intern Med [Internet]. 1996 [citado 16 Mar 2025];35(8):629-36. Disponible en: https://pubmed.ncbi.nlm.nih.gov/8894737/
21-Karim MY, Alba P, Cuadrado MJ, Abbs IC, D’Cruz DP, Khamashta MA, et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford) [Internet]. 2002 [citado 16 Mar 2025];41(8):876-82. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12154204/
22-Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al. Morbidity and mortality in systemic lupus erythematosus during 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) [Internet]. 1999 [citado 16 Mar 2025];78(8):167-75. Disponible en: https://pubmed.ncbi.nlm.nih.gov/10352648/
23-Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”. Medicine (Baltimore) [Internet]. 2004 [citado 16 Mar 2025];83(1):1-17. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14747764/
24-Fessler BJ. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol [Internet]. 2002 [citado 16 Mar 2025];16(2):181-91. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12041954/
25-Bunkhorst R, Eberhardt OK, Haubitz M, Brunkhorst FM. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med [Internet]. 2000 [citado 16 Mar 2025];26(Suppl2):S199-201. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18470720/
26-Shin KC, Lee YJ, Kang SW, Baek HJ, Lee EB, Kim HA et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis [Internet]. 2001 [citado 16 Mar 2025];60(10):988-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11589181/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dianayis Hortelas Sánchez, Thuyen Fong Fernández, Ana María Gutiérrez Guadarrama, Gretchen Garrido Muñoz, Katiuska Rodríguez Pérez, Yaliana Frómeta Barrera
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
